CX 2026 Registration
CX Executive Board
CX 2026 Programme
CX 2026 – The 48th Charing Cross Symposium
The Charing Cross (CX) Symposium continues to set the standard in vascular and endovascular education, shaping the future of practice worldwide. CX 2026 marked the final chapter of our current three-year cycle, designed to spark debate on the biggest controversies in the field. Our distinguished faculty of global experts critically examined the evidence, exchanged perspectives, and worked towards building consensus on the issues that matter most.
Consensus was the defining theme for CX 2026. We welcomed an international community of specialists, educators, and innovators to tackle the pressing challenges in vascular and endovascular medicine—challenges that directly impact patient outcomes and clinical decision-making.
In 2024, CX found a new home at ExCeL London, unlocking fresh opportunities for immersive, hands-on learning. The expanded workshop programme has gone from strength to strength, offering delegates practical skills alongside groundbreaking evidence and innovation. In 2026, we returned once again to London’s premier conference and exhibition venue to deliver an agenda packed with cutting-edge science, expert debate, and future-shaping education.
Stay connected—sign up for the CX Newsletter and be the first to hear the latest updates.
CX Co-Chairs
Latest CX news
CX Vascular Access Course inaugural session aims to produce ischaemic steal syndrome consensus
The new CX Vascular Access Course began yesterday with a masterclass on vascular access-induced ischaemic steal syndrome. Exploring the mechanisms and pathophysiology of ischaemia in vascular access, the ultimate target of the course was [...]
CX Peripheral Live and Edited Cases: Why a technology is chosen for a particular situation
As part of this year’s Peripheral Arterial Main Programme, Charing Cross yesterday hosted a series of live cases from Münster, Germany. There were also a number of edited cases presented by Faculty from across [...]
Good day for drug-coated balloons, swirling flow stents and drug-eluting stents at CX
Yesterday’s Peripheral Arterial Challenges session saw a host of new developments being presented and a lift for drug-coated balloons (DCBs), swirling flow stents and drug-eluting stents. The day began by trying to avoid any [...]